The HepNet Study House, established by the German Liver Foundation, is a virtual house where all cooperation in the field of clinical studies on acute and chronic viral hepatitis merges.
Detailed description
Being an external partner of the German Liver Foundation, the DZIF can use the HepNet Study House as a platform for establishing patient cohorts and for conducting clinical trials. The virtual house connects study centers doing research on hepatitis.
The largest trial on the treatment of aggressive hepatitis D (delta) worldwide was conducted at the German Liver Foundation’s HepNet Study House. It shows that an extension of treatment duration has
Professor Markus Cornberg and his translational research group provide the necessary link between hospitals, the HepNet Study House trial platform and scientific activities at the DZIF. At the Hannover Medical School, Cornberg is clinically responsible for the Hepatitis Outpatient Clinic and for the ...
The HepNet Study-House connects individual trial centres in the hepatitis research field, creating a central platform for conducting clinical trials (investigator initiated trials). In addition, it establishes patient cohorts for viral hepatitis research. On the one hand, the Study-House is a point ...
For the first time, a German Liver Foundation trial shows that the chronic hepatitis C drugs developed in the last years can also cure acute hepatitis C—even faster than the chronic disease. The trial
